News About: Pharm. Industry
Hyundai Pharm seeking higher share in OTC market
Hyundai Pharm is churning out its customer-friendly OTC products in the domestic OTC market amid business slumps.
These products include a multivitamin supplement, a liver protectant and nutritional supplement con...
Elder son named Hanmi Pharm chief
Lim Chong-yun, the first son of Hanm Pharm Chairman Lim Sung-ki, has been appointed president of the company.
Lim was elected as president of Hanmi at the last general shareholders meeting.
He has served as pres...
Boram acquires Newgex
Boram Pharm announced on March 31 that it has acquired Newgex, Inc., a local biopharmaceutical company and that this acquisition will add growth momentum to Boram’s research and development projects.
The merged co...
Patients and civic groups call for compulsory license over Roche’s AIDS drug
The government should break the Swiss drug giant Roche’s patent of AIDS drug Fuzeon by applying a "compulsory license" in a bid to protect the public interest, according to Korean patients and activists.
In a forum...
Drugmakers in race for OTC market
Domestic and foreign drugmakers are vying for a bigger share of domestic OTC market.
UCB Korea, a Korean unit of Belgium based UCB Group, is looking to expand their presence with Zyrtec (cetirizine) by offering var...
Hyperlipemia drugmakers face dilemma
It is a challenging time for domestic and foreign hyperlipemia drugmakers.
These companies face a bashing by from the government and outer negative factors – lowing price cut and failing to meet soaring raw materi...
KPMA advocates Vision 2012
The Korea Pharmaceutical Manufacturers Association unveiled its plan to expand its annual spending on a range of research and development (R&D) activities to strengthen the country’s growth potential.
Under the pro...
GCJBP to submit clinical data of Laennec placenta injection
GCJBP, a local importer of Laennec placenta injection from Japan Bio Products (JBP), says it is scheduled to submit clinical data of Laennec placenta injection to the Korea Food and Drug Administration at the end of t...
Myungmoon steps up support for biopharmaceutical business
Myungmoon Pharm has a new objective to advance into biopharmaceutical business sector while securing new engines for future growth.
The biopharmaceutical market was estimated to be worth over $79 billion in 2007 wi...
Creagene-Choongwae merger expected during May 1
Creagene Holdings’ merger with Choong-wae Pharm is due on May 1, it was announced at the special shareholders meeting of Creagene on March 27.
With appointment of three directors, Creagene-Choongwae merger is expec...
